About Silk Road Medical Inc

Silk Road Medical, Inc.,is a medical device company located in Sunnyvale, California, that is focused on reducing the risk of stroke and its devastating impact. The company's flagship procedure, TransCarotid Artery Revascularization (TCAR), is clinically proven to treat blockages in the carotid artery at risk of causing a stroke.

CEO

Erica Rogers

Employees

281

Headquarters

1213 Innsbruck Dr
Sunnyvale, California 94089-1317
Phone: 16505669060
silkroadmed.com

News

Silk Road Medical downgraded at Argus on CMS coverage decision
Sep 21, 2023 16:42pm

Argus has downgraded Silk Road Medical to hold after CMS covered a competing product. Read more here.

Source:Seeking Alpha

Medical Device Provider Silk Road Pioneers Innovative Stroke Prevention Method: Analyst
Sep 06, 2023 18:52pm

Oppenheimer has initiated coverage on Silk Road Medical Inc (NASDAQ: SILK ) with an Outperform rating and price target of $30 . Analysts Suraj Kalia and Shaymus Contorno note that Silk Road Medical has been at the forefront of introducing the Transcarotid Artery Revascularization (TCAR) method, an innovative procedure for stroke prevention in patients with carotid stenosis. Since its approval in 2015, SILK''s revenues have grown impressively, with a four-year CAGR of 42%, leading to yearly sales of around $182 … Full story available on Benzinga.com

Source:Benzinga

Citi maintains Silk Road Medical at ''buy'' with a price target of $35.00
Aug 14, 2023 09:04am

https://www.investing.com/news/pro/silk-road-medical-inc-receives-investment-bank-analyst-rating-update-3153246

Source:Investing.com

Silk Road Medical: Unsure On Economics Given List Of Probabilities (Rating Downgrade)
Aug 10, 2023 07:50am

The outlook for Silk Road Medical is mixed, with potential capital budgeting constraints and exogenous risks from the marketplace. See why SILK stock is a Hold.

Source:Seeking Alpha